Sartorius Opens New York Demonstration Lab
A new demonstration facility in New York gives Sartorius’ customers hands-on access to bioprocessing systems and lab instruments.
Mary Lavin, president of the Sartorius companies in North America, leads the ribbon cutting ceremony at the company’s New York Sartorius Application Center in Bohemia. Town of Islip Supervisor Angie M. Carpenter (left), members of the Sartorius Executive Committee, and local officials participated in the ceremony. Photo courtesy of Sartorius.
Sartorius has opened its first North American demonstration laboratory in Bohemia, NY to provide customers with access to the company’s upstream and downstream processing systems and laboratory products. The laboratory, part of the company’s new 40,000-sq-ft facility, features hands-on demonstration stations, as well as classroom learning space.
The Long Island-based Sartorius Application Center is modeled after similar application centers in China and Germany. In the FlexLab, customer can view FlexAct systems, Sartocheck bag testers, and TAP Biosystems equipment. Laboratory products on display include scales, balances, and liquid handling systems. In addition, an R&D section showed developments in bioreactors and freeze/thaw equipment.
At a grand opening event on June 2, Sartorius hosted customers, employees, the media, and local government officials for a ribbon-cutting ceremony and facility tours with introductions provided by Mary Lavin, the company’s president for North America.
Source: Sartorius
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
